set up a mathematical model to test a hunch.
The hunch is that HIV may not always want to go unnoticed. It's known that HIV replicates more efficiently in T H cells that have been activated, and this presents the virus with a bit of a dilemma-it certainly doesn't pay to be recognized by CTLs, the hired assassins of the immune system. But there's also a possible benefit in triggering the activation of the T H cells that they've infected. Where does the balance lie? Is it conceivable that there are some conditions where it's better for HIV epitopes to be recognized than to be ignored?
In answer, the authors model the complex network of interactions between T H cells, CTLs, antigen-presenting cells and viruses (see image). They set up two different versions of the model-one with a virus that infects non-immune cells (like HCV infecting hepatocytes), and one with a virus that infects T cells (like HIV). The results are quite striking-in the case of HCV, evasion always pays off. But in the case of HIV, the dependence on T H activation seems to sometimes favor viral epitopes that are strongly recognized by cellular immune system.
Using their combination of sequence data analysis and mathematical modeling, the authors propose that recognition of HIV epitopes by T H cells can be beneficial for the long-term survival of the virus within the body. Conditions identified in the model suggest that this recognition exerts its influence during the process of ''trans-infection'', a feature of the chronic stage of HIV-related disease whereby T H cells become infected during their activation in the lymph nodes. Another key variable is how many T H cells are activated in the body by pathogens other than HIV. If this ''background activation'' is strong, HIV obtains no payoffs from being recognized. Studying the sequence data confirms that in the capsid genes (Gag) it is T H epitopes, rather than CTL epitopes, that are constrained and that epitopes stay the same within patient viral populations rather than between patients, again implicating chronic internal transmission between cells.
The authors' hypothesis highlights the intriguing effects of opposing selective forces on HIV genome sequence, but they also point out that there is a potentially important practical implication of their findings. If their model is correct, then HIV vaccines based on T H epitopes might prove counterproductive, playing into the hands of the virus. Instead, vaccines should target only CTL-specific viral epitopes. 
